In agreement with the previous data in SUFU-deficient and pancreatic cancer cells, inhibition of DYRK1B but not of DYRK1A reduced GLI1 protein levels (Figure 3G, right panel). This evidence concerns the gene DYRK1A and familial pancreatic carcinoma.